Neuphoria Therapeutics (NEUP) Other Non-Current Assets (2021 - 2025)
Historic Other Non-Current Assets for Neuphoria Therapeutics (NEUP) over the last 5 years, with Q4 2025 value amounting to $79647.0.
- Neuphoria Therapeutics' Other Non-Current Assets rose 765.73% to $79647.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $79647.0, marking a year-over-year increase of 765.73%. This contributed to the annual value of $77945.0 for FY2025, which is N/A changed from last year.
- Latest data reveals that Neuphoria Therapeutics reported Other Non-Current Assets of $79647.0 as of Q4 2025, which was up 765.73% from $78564.0 recorded in Q3 2025.
- In the past 5 years, Neuphoria Therapeutics' Other Non-Current Assets ranged from a high of $86691.6 in Q4 2021 and a low of $73982.0 during Q4 2024
- For the 5-year period, Neuphoria Therapeutics' Other Non-Current Assets averaged around $79869.3, with its median value being $79534.9 (2023).
- In the last 5 years, Neuphoria Therapeutics' Other Non-Current Assets tumbled by 668.85% in 2023 and then soared by 765.73% in 2025.
- Neuphoria Therapeutics' Other Non-Current Assets (Quarter) stood at $86691.6 in 2021, then fell by 1.68% to $85235.9 in 2022, then decreased by 6.69% to $79534.9 in 2023, then decreased by 6.98% to $73982.0 in 2024, then rose by 7.66% to $79647.0 in 2025.
- Its Other Non-Current Assets stands at $79647.0 for Q4 2025, versus $78564.0 for Q3 2025 and $77945.0 for Q2 2025.